Most Read News

As part of the terms, the sellers will face a 60-day lock-up, restricting them from selling any additional shares during this period.

The price stated is a discount of about 7% to Emcure Pharma’s closing price of ₹1,394.10 on the NSE on November 17, 2025.

The project utilises advanced DCR cells and bifacial modules and required the installation of around 7.75 lakh solar panels across harsh desert terrain.

EBITDA margin grew to 25.5 percent, significantly higher than the 14 percent margin reported in the previous quarter.

The lab aims to support G2000 companies by allowing them to experiment with new AI-driven solutions, incubate real-world use cases and expand physical AI projects to improve operational competitiveness.

The company operates across multiple geographies through subsidiaries and has a growing presence in international projects.

Infosys will guide companies through the full lifecycle of GCC setup and transformation.

The Port SPV will develop, own, and operate a 27 Million Tonnes Per Annum (MTPA) greenfield Port in Dhofar Governorate situated in Oman.

Here are some of the stocks that may see significant price movement today: Emcure Pharma, Tata Power, One 97 Communications, etc.

AstraZeneca will continue to hold the intellectual property, manage the import licence, and retain the Marketing Authorisation for the drug.